RC
LH icon

RegentAtlantic Capital’s Labcorp LH Stock Holding History

RegentAtlantic Capital’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$384K Buy
2,180
+215
+11% +$44K 0.01% 512
2022
Q2 		$396K Buy
1,965
+65
+3% +$13.9K 0.01% 485
2022
Q1 		$430K Sell
1,900
-74
-4% -$17.4K 0.01% 492
2021
Q4 		$533K Sell
1,974
-1
-0.1% -$248 0.01% 440
2021
Q3 		$478K Buy
1,975
+101
+5% +$25.5K 0.01% 447
2021
Q2 		$444K Sell
1,874
-26
-1% -$5.92K 0.01% 453
2021
Q1 		$416K Sell
1,900
-12
-0.6% -$2.41K 0.01% 416
2020
Q4 		$334K Buy
1,912
+37
+2% +$6.39K 0.01% 409
2020
Q3 		$303K Sell
1,875
-27
-1% -$4.28K 0.01% 400
2020
Q2 		$271K Sell
1,902
-802
-30% -$111K 0.02% 406
2020
Q1 		$294K Buy
2,704
+76
+3% +$10.9K 0.02% 335
2019
Q4 		$382K Sell
2,628
-55
-2% -$7.94K 0.02% 346
2019
Q3 		$387K Sell
2,683
-135
-5% -$19.7K 0.03% 338
2019
Q2 		$419K Buy
2,818
+328
+13% +$45.8K 0.03% 317
2019
Q1 		$327K Sell
2,490
-541
-18% -$66.6K 0.02% 345
2018
Q4 		$329K Buy
3,031
+1,086
+56% +$145K 0.03% 330
2018
Q3 		$290K Buy
1,945
+47
+2% +$7.15K 0.02% 363
2018
Q2 		$293K Hold
1,898
– – 0.03% 350
2018
Q1 		$264K Sell
1,898
-41
-2% -$6.02K 0.02% 359
2017
Q4 		$266K Hold
1,939
– – 0.02% 372
2017
Q3 		$252K Sell
1,939
-35
-2% -$4.67K 0.02% 365
2017
Q2 		$261K Buy
1,974
+9
+0.5% +$1.1K 0.02% 354
2017
Q1 		$242K Sell
1,965
-233
-11% -$27.6K 0.02% 363
2016
Q4 		$242K Hold
2,198
– – 0.02% 347
2016
Q3 		$260K Buy
2,198
+350
+19% +$41.2K 0.03% 340
2016
Q2 		$207K Buy
+1,848
New +$199K 0.02% 359
2015
Q3 		– Sell
-1,918
Closed -$200K – 377
2015
Q2 		$200K Sell
1,918
-217
-10% -$22.6K 0.02% 358
2015
Q1 		$231K Buy
2,135
+287
+16% +$29.5K 0.02% 326
2014
Q4 		$171K Buy
+1,848
New +$163K 0.01% 380

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

RegentAtlantic Capital's LH Position: Q3 2022 in Review

RegentAtlantic Capital increased its Labcorp (LH) stake by 11% in Q3 2022, buying an estimated $44K and bringing the position to 2,180 shares worth $384K. The position accounts for 0.01% of the portfolio, ranked #512.

RegentAtlantic Capital first reported a position in LH in Q4 2014 and has held it in 29 quarters since. The position peaked at $533K in Q4 2021. 936 funds tracked by Wall St. Rank hold LH as of Q3 2022.

  • RegentAtlantic Capital held 2,180 shares of Labcorp worth $384K as of Q3 2022.
  • RegentAtlantic Capital bought 215 Labcorp shares in Q3 2022, an estimated $44K.
  • Labcorp made up 0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #512 holding.
  • RegentAtlantic Capital first reported a position in Labcorp in Q4 2014 and has held it in 29 quarters since.
  • RegentAtlantic Capital's Labcorp position peaked at $533K in Q4 2021.
  • 936 funds tracked by Wall St. Rank held Labcorp as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.